# ENDRA Life Sciences Inc.: Form 8-K, filed Sep 25, 2020

- Company: [ENDRA Life Sciences Inc.](/companies/ndra.md) (CIK 1681682)
- Form: 8-K
- Filed: 2020-09-25
- Accepted by EDGAR: Sep 25, 2020, 16:54 ET
- Period: 2020-09-25
- Accession: 0001654954-20-010481
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1681682/000165495420010481/ndra_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1681682/000165495420010481/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1681682/000165495420010481/ndra_8k.htm

Filed Sep 25, 2020.
Source: SEC EDGAR, the filing index for accession 0001654954-20-010481. Last ingested by Listed: Nov 10, 2026, 17:03 ET. No prices; not investment advice.
